Cutaneous Manifestations of Pediatric Hematological Malignancies: A Narrative Review
Authors:
Open Access
- 1 April 2025
- journal article
- Published by Wolters Kluwer Health in Indian Journal of Paediatric Dermatology
- Vol. 26 (2) , 79-89
Abstract
Malignancies in the pediatric population can cause significant morbidity and mortality in the affected individual. Hematological malignancies are the most common type of cancer in children. Moreover, its incidence has drastically increased due to genetic alterations or environmental exposure to several carcinogens. Cutaneous manifestations, although rare, may be the sole presentation and may precede, follow or occur simultaneously with the primary disease. Hence, it is important to be aware about the varied morphology, distribution, and evolution of the lesions for prompt diagnosis and treatment. However, there is a paucity of the literature in the pediatric population. The objective of the review is to enumerate the different cutaneous symptoms and signs of hematological malignancies due to the primary disease, chemotherapy, and stem-cell transplantation in children.Keywords
This publication has 73 references indexed in Scilit:
- Management of oral mucositis in pediatric patients receiving cancer therapy: A systematic review and meta‐analysisPediatric Blood & Cancer, 2018
- Cutaneous Graft-Versus-Host Disease: Diagnosis and TreatmentAmerican Journal of Clinical Dermatology, 2017
- The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2017
- Immune-Mediated Complications after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2016
- Outcomes After Diagnosis of Mycosis Fungoides and Sézary Syndrome Before 30 Years of AgeJAMA Dermatology, 2014
- Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancerEuropean Journal of Clinical Pharmacology, 2013
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Particular cutaneous side effects with etoposide-containing courses: is VP16 or etoposide phosphate responsible?Cancer Chemotherapy and Pharmacology, 2004
- The burdens of cancer therapyCancer, 2003
- Unusual skin rash following withdrawal of oral 6‐mercaptopurine in children with leukemiaMedical and Pediatric Oncology, 1987